| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.38B | 6.27B | 8.02B | 7.90B | 6.68B |
| Gross Profit | 2.21B | 2.18B | 2.18B | 2.23B | 1.65B |
| EBITDA | 2.59B | 2.60B | 4.53B | 2.58B | 1.61B |
| Net Income | 2.19B | 2.02B | 2.46B | 3.85B | 7.46B |
Balance Sheet | |||||
| Total Assets | 84.32B | 82.33B | 80.46B | 75.38B | 68.92B |
| Cash, Cash Equivalents and Short-Term Investments | 2.67B | 2.78B | 3.65B | 5.57B | 3.79B |
| Total Debt | 29.23B | 28.25B | 27.06B | 22.09B | 13.75B |
| Total Liabilities | 33.42B | 33.15B | 32.71B | 28.21B | 22.26B |
| Stockholders Equity | 49.42B | 47.71B | 46.32B | 44.86B | 45.27B |
Cash Flow | |||||
| Free Cash Flow | -172.95M | -772.01M | -3.37B | -3.55B | -4.89B |
| Operating Cash Flow | 1.47B | 2.02B | 1.99B | 1.81B | 1.31B |
| Investing Cash Flow | -1.66B | -2.43B | -4.57B | -4.85B | -7.01B |
| Financing Cash Flow | -3.38M | -423.24M | 1.38B | 4.78B | 5.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$10.40B | 5.27 | 8.59% | 4.37% | 0.90% | 11.31% | |
71 Outperform | HK$13.25B | 8.20 | 7.72% | 6.19% | 7.14% | 3.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$21.97B | 6.57 | 4.55% | 4.21% | 4.50% | 12.58% | |
61 Neutral | HK$795.19M | 3.38 | 6.03% | ― | -14.62% | -19.99% | |
46 Neutral | HK$885.98M | -4.13 | -7.92% | 5.36% | -2.70% | -3800.00% | |
44 Neutral | HK$4.85B | -0.83 | -30.08% | ― | 0.62% | -58.08% |